{"chebi_id":"64153","chebi_name":"tanespimycin","chebi_synonyms":["17-(Allylamino)-17-demethoxygeldanamycin","(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate","17-demethoxy-17-(2-propenylamino)geldanamycin","17-(Allylamino)geldanamycin","17-Demethoxy-17-allylamino geldanamycin","17-allylaminogeldanamycin","17AAG","17-N-allylamino-17-demethoxygeldanamycin","17-AAG","tanespimycine","tanespimycinum","NSC 330507","NSC-330507","tanespimycina"],"diffprof_id_observed":["MTBLS4820_0002_00000001"],"diffprof_id_var_observed":["MTBLS4820_0002_00000001"],"inchikey":"AYUNIORJHRXIBJ-TXHRRWQRSA-N","inn_name":"tanespimycinum","iupac_name":"(4<i>E</i>,6<i>Z</i>,8<i>S</i>,9<i>S</i>,10<i>E</i>,12<i>S</i>,13<i>R</i>,14<i>S</i>,16<i>R</i>)-13-hydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3,20,22-trioxo-19-(prop-2-en-1-ylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18-pentaen-9-yl carbamate","num_study_observed":1,"reactome_ids":["R-HSA-1236382","R-HSA-1643685","R-HSA-1643713","R-HSA-5637810","R-HSA-5637812","R-HSA-5637815","R-HSA-5663202"],"reactome_names":["Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants","Disease","Signaling by EGFR in Cancer","Constitutive Signaling by EGFRvIII","Signaling by EGFRvIII in Cancer","Signaling by Ligand-Responsive EGFR Variants in Cancer","Diseases of signal transduction by growth factor receptors and second messengers"],"study_id_observed":["MTBLS4820"],"study_id_var_observed":["MTBLS4820"],"synonym_name":"17-Demethoxy-17-allylamino geldanamycin"}